Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Vertex cystic fibrosis drug gets expanded approval for use in infants

      Vertex cystic fibrosis drug gets expanded approval for use in infants

      Ruby Khatun Khatun19 Aug 2018 9:30 AM IST
      U.S. health regulators have expanded the use of one of Vertex Pharmaceuticals Inc's cystic fibrosis drugs to include patients aged between 12 months...
      Health Ministry publishes draft on standards for medical devices, Invites Comments

      Health Ministry publishes draft on standards for medical devices, Invites Comments

      Ruby Khatun Khatun18 Aug 2018 5:39 PM IST
      Guidance Document is now available to seek stakeholder’s comments till 01/09/2018 (30 calendar days).New Delhi: The Ministry of Health and Family...
      AstraZeneca Pharma India gets DCGI approval to market cancer drug in India

      AstraZeneca Pharma India gets DCGI approval to market cancer drug in India

      Ruby Khatun Khatun18 Aug 2018 11:00 AM IST
      New Delhi: Drug firm AstraZeneca Pharma India said it has received permission from the Drug Controller General of India (DCGI) to import and market...
      FDA approves first generic version of EpiPen

      FDA approves first generic version of EpiPen

      Ruby Khatun Khatun18 Aug 2018 10:15 AM IST
      The U.S. Food and Drug Administration approved the first generic version of EpiPen and EpiPen Jr (epinephrine) auto-injector for the emergency...
      Apollo Hospitals Q1 net up 71 percent at Rs 60 crore

      Apollo Hospitals Q1 net up 71 percent at Rs 60 crore

      Ruby Khatun Khatun18 Aug 2018 10:00 AM IST
      New Delhi: Apollo Hospitals posted a 71.02 increase in its standalone profit after tax (PAT) at Rs 60.2 crore for the first quarter ended June 30.The...
      China sacks six senior officials at food and drug regulator over vaccine scandal

      China sacks six senior officials at food and drug regulator over vaccine scandal

      Ruby Khatun Khatun18 Aug 2018 9:45 AM IST
      SHANGHAI: China said it has sacked six senior officials at its food and drug regulator after a safety scandal at vaccine maker Changsheng...
      Trivitron’s Kiran launches complete portfolio of Advanced Digital X-Ray, DSA C-Arm, Modular Smart OT Solutions

      Trivitron’s Kiran launches complete portfolio of Advanced Digital X-Ray, DSA C-Arm, Modular Smart OT Solutions

      Ruby Khatun Khatun18 Aug 2018 9:30 AM IST
      Mumbai: Kiran Medical Systems, the Radiology Division of Trivitron Healthcare launches complete portfolio of Advanced Digital X-Ray systems, DSA...
      Sun Pharma gets USFDA approval for CEQUA to treat dry eye

      Sun Pharma gets USFDA approval for CEQUA to treat dry eye

      Ruby Khatun Khatun17 Aug 2018 12:59 PM IST
      New Delhi: Sun Pharma has received approval from the US health regulator for CEQUA (cyclosporine ophthalmic solution), used to increase tear...
      Oxytocin Ban: AIDAN reaches Court, Govt Asked for explanation

      Oxytocin Ban: AIDAN reaches Court, Govt Asked for explanation

      Ruby Khatun Khatun17 Aug 2018 10:58 AM IST
      The plea by AIDAN follows concerns raised by doctors over constraints that could emerge in the supply of Oxytocin, used to treat excessive bleeding in...
      Abbott India net profit rises 70.78 percent at Rs 82.40 crores

      Abbott India net profit rises 70.78 percent at Rs 82.40 crores

      Ruby Khatun Khatun17 Aug 2018 10:15 AM IST
      Mumbai: Pharma Major, Abbott India Ltd has posted a rise of 70.78 percent in its net profit at Rs 82.40 crores for the quarter ended June 30, 2018, as...
      FDA approves new vaginal ring for one year of birth control

      FDA approves new vaginal ring for one year of birth control

      Ruby Khatun Khatun17 Aug 2018 10:00 AM IST
      The U.S. Food and Drug Administration (FDA) approved Annovera (segesterone acetate and ethinyl estradiol vaginal system), which is a combined hormonal...
      Policybazaar appoints Ashish Gupta as CEO of healthtech venture DocPrime

      Policybazaar appoints Ashish Gupta as CEO of healthtech venture DocPrime

      Ruby Khatun Khatun17 Aug 2018 9:45 AM IST
      New Delhi: Insurance portal Policybazaar said it has appointed Ashish Gupta as the Chief Executive Officer of its new health tech venture, DocPrime....
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok